AWARD TO ANTAGEN PHARMACEUTICALS
$300,000
| Recipient | ANTAGEN BIOSCIENCES INC UEI HXD6EFH2ND57 |
|---|---|
| Award ID | 75N93022C00020 |
| Award amount | $300,000 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — National Institutes of Health |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | AN12 |
| Set-aside | Small business |
| Start date | Jul 5, 2022 |
| End date | Jun 30, 2023 |
| Place of performance | CANTON, MA |
| Record updated | Feb 17, 2023 |
View the official award record
More awards won by ANTAGEN BIOSCIENCES INC
SBIR TOPIC 081: ADJUVANT DEVELOPMENT FOR VACCINES AGAINST INFECTIOUS OR IMMUNE-MEDIATED DISEASES
Department of Health and Human Services · $600,000 · Sep 1, 2020
THE OBJECTIVE OF THIS CONTRACT IS TO USE IMMUNOGENS (ENVS) COMBINED WITH EFFECTIVE MULTIVALENT ANTIGENIC DISPLAY ON NANOPARTICLES (NPS) FOR DELIVERY TO PROMOTE STRONG AND LONG-LIVED NEUTRALIZING ANTIBODY RESPONSES AGAINST HIV AND DIRECT AFFINITY MATURATION TOWARD HIV NEUTRALIZING ANTIBODIES.
Department of Health and Human Services · $599,914 · Jun 17, 2019
THE GOAL OF THE PROPOSED PROJECT IS TO FURTHER DEVELOP ANTAGEN'S NOVEL PROTEIN NANOPARTICLE-BASED EXPRESSION AND DELIVERY SYSTEM USING FCRIDER TECHNOLOGY AND ANTIBODY AFUCOSYLATION TECHNOLOGY TO PRODUCE A2,6-SIALYLATED AFUCOSYLATED ENV-FCRIDER (
Department of Health and Human Services · $299,998 · Jul 1, 2022
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids